AR882 Effectively Lowers Serum Urate Levels in Patients With Gout
After 12 weeks of treatment, the median sUA levels of patients with gout were reduced from 8.6 mg/dL to 3.6 mg/dL in the AR882 75 mg cohort and 5.0 mg/dL in the AR882 50 mg group.
United States Robertt Keenan Roy Fleischmann European Congress Metroplex Clinical Research Center American College Of Rheumatology
Source: hcplive.com